HighCape Capital Acquisition Corp, trading under the ticker CAPA, is a blank-check company sponsored by HighCape Capital Management that completed its initial public offering in 2020 targeting the life sciences and healthcare technology sector. The company filed an amended quarterly report, Form 10-Q/A, with the SEC on June 10, 2021, under accession number 0001104659-21-079104, reflecting updated disclosures tied to its planned business combination with Quantum-Si Incorporated, a semiconductor-based protein sequencing company. The de-SPAC transaction with Quantum-Si represented a bet on next-generation sequencing technology at the intersection of genomics and semiconductor engineering. Sign up at SpacDesk for full filing history, sponsor profiles, and real-time deal tracking on CAPA and hundreds of other SPACs.